World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
65
Citations
14914
World Ranking
2508
National Ranking
25

Overview

Juhani Eskola is affiliated with the Finnish Institute for Health and Welfare (THL) in Finland. Their research primarily spans the fields of medicine, economics, econometrics and finance, and social sciences, with a focus on public health and related economic evaluations.

Their work addresses multiple subfields including economics and econometrics, health, epidemiology, general health professions, and infectious diseases. The main topics covered by Eskola's research include vaccine coverage and hesitancy, health systems, economic evaluations, quality of life, pharmaceutical economics and policy, child and adolescent health, pneumonia and respiratory infections, respiratory viral infections research, and SARS-CoV-2 and COVID-19 research.

Eskola has published research in various peer-reviewed journals. Frequent publication venues include:

  • Value in Health
  • Expert Review of Vaccines
  • Vaccine

Recent papers authored or co-authored by Eskola illustrate a consistent focus on vaccines and immunisation programmes. These include:

  • "Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union's Regulation on Health Technology Assessment for Vaccines," 2024, Value in Health
  • "Assessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives," 2024, Expert Review of Vaccines
  • "Considerations for unblinding individual study participants during vaccine trials," 2023, Vaccine

Frequent co-authors collaborating with Eskola highlight ongoing partnerships within the vaccine research community. These collaborators include:

  • Ugne Sabale
  • Nathalie Largeron
  • Paolo D'Agostino
  • Ruth Chapman
  • Dávid Dankó

The research outputs indicate a blend of clinical and economic perspectives on vaccines and immunisation policies, particularly with respect to evaluation frameworks and national health programmes. The work on vaccine hesitancy and coverage further reflects an interest in public acceptance and implementation aspects of vaccination strategies.

Eskola's contribution to economic evaluations, quality of life metrics, and pharmaceutical policy situates their research at the intersection of health outcomes and economic impact, supporting policy-relevant discourse in health technology assessment and immunisation practices across Europe.

Best Publications

  • Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

    Eskola J;Kilpi T;Palmu A;Jokinen J

  • Addressing the vaccine confidence gap

    Heidi J Larson;Louis Z Cooper;Juhani Eskola;Samuel L Katz

  • Global epidemiology of invasive meningococcal disease.

    Rabab Z Jafri;Asad Ali;Nancy E Messonnier;Carol Tevi-Benissan

  • A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

    J Eskola;H Käyhty;A K Takala;H Peltola

  • Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

    Unknown

  • Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

    Ron Dagan;Juhani Eskola;Claude Leclerc;Odile Leroy

  • Epidemiology of invasive pneumococcal infections in children in Finland.

    Juhani Eskola;Aino K. Takala;Eija Kela;Eeva Pekkanen

  • Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.

    J Eskola;H Peltola;A K Takala;H Käyhty

  • Pneumococcal conjugate vaccines.

    Juhani Eskola;Merja Anttila

  • Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

    Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen

  • Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

    Steven Black;Juhani Eskola;Claire Anne Siegrist;Neal Halsey

  • Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis

    Juhani Eskola;Joel Ward;Ron Dagan;David Goldblatt

  • Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

    Helena Käyhty;Heidi Åhman;Pirjo-Riitta Rönnberg;Risto Tillikainen

  • Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

    Juhani Eskola;Rose-Marie Ölander;Tapani Hovi;Leila Litmanen

  • Avidity of IgG for Streptococcus pneumoniae Type 6B and 23F Polysaccharides in Infants Primed with Pneumococcal Conjugates and Boosted with Polysaccharide or Conjugate Vaccines

    Merja Anttila;Juhani Eskola;Heidi Åhman;Helena Käyhty

  • Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.

    Heidi Åhman;Helena Käyhty;Pirjo Tamminen;Arja Vuorela

  • Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

    Heidi Åhman;Helena Käyhty;Hannele Lehtonen;Odile Leroy

  • How to deal with vaccine hesitancy

    Juhani Eskola;Philippe Duclos;Melanie Schuster;Noni E MacDonald

  • The causes of hospital-treated acute lower respiratory tract infection in children.

    Hanna Nohynek;Juhani Eskola;Eija Laine;Pekka Halonen

  • Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children.

    Nohynek H;Valkeila E;Leinonen M;Eskola J

  • Risk factors of invasive Haemophilus influenzae type b disease among children in Finland

    Aino K. Takala;Juhani Eskola;Juni Palmgren;Pirjo-Riitta Rönnberg

Frequent Co-Authors

Helena Käyhty
Helena Käyhty Finnish Institute for Health and Welfare (THL)
Heikki Peltola
Heikki Peltola University of Helsinki
Maija Leinonen
Maija Leinonen Finnish Institute for Health and Welfare (THL)
P. Helena Mäkelä
P. Helena Mäkelä University of Helsinki
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev
Tapani Hovi
Tapani Hovi National Institutes of Health
Keith P. Klugman
Keith P. Klugman Bill & Melinda Gates Foundation
Claire-Anne Siegrist
Claire-Anne Siegrist University of Geneva
Steven Black
Steven Black Cincinnati Children's Hospital Medical Center
Erkki Savilahti
Erkki Savilahti University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related fields that blend science with practical applications. For students interested in healthcare, exploring pathways like becoming a ccls certification professional can provide specialized roles supporting patient well-being. This certification can complement a microbiology background by focusing on emotional care in medical settings.

For those facing unique challenges, such as individuals seeking online degrees for felons, there are accessible programs that offer a fresh start and career growth. Microbiology-related courses may be part of these flexible degree options, emphasizing that past setbacks don’t necessarily limit future opportunities.

Another critical pathway is within nursing, where microbiology knowledge is valuable for specialized roles like a functional medicine nurse practitioner salary reflects the increasing demand for integrative care providers skilled in understanding disease mechanisms and patient treatment.

Additionally, careers in healthcare administration, such as becoming a certified professional coder (cpc), can also intersect with microbiology through medical billing and coding jobs in clinical laboratories and hospitals. These roles ensure that healthcare services are accurately documented and reimbursed, supporting laboratory operations indirectly.

Best Scientists Citing Juhani Eskola

Trending Scientists